Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
With known benefits on metabolic health and possible direct effects on vascular function, GLP-1 agonists could help manage walking limitations in patients with PAD
Advantages: Greatest long-term weight loss (2540%) Strong improvements or resolution of diabetes and other conditions Considerations: Invasive with incisions Longer recovery (26 weeks) Higher surgical risks Requires lifelong dietary adjustments and vitamin supplementation GLP-1 Medications : Powerful, Non-Surgical Support GLP-1 receptor agonists (such as semaglutide and tirzepatide) are injectable medications that help reduce appetite, improve insulin sensitivity, and support weight loss
Diabetes of the Feet Diabetic Neuropathy may lead to damaged nerves and affect the feet through numbness and loss of sensation
Great work, Cam
Excess body weight places increased mechanical stress on weight-bearing joints, accelerating cartilage degradation and contributing to pain and functional limitation
